Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Rigel Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.
Revenue was down $64.28 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 21.12% increase in the share price the next day.
Here's a look at Rigel Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.10 | -0.11 | |
| EPS Actual | -0.11 | -0.12 | -0.08 | 0.22 |
| Revenue Estimate | 21.90M | 23.56M | 20.37M | 31.05M |
| Revenue Actual | 20.41M | 21.54M | 26.27M | 81.02M |
To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
